New Scoops

Cardiovascular Agents market  was valued at $XX million in 2017, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2017 and 2028. Download free sample copy @  https://www.radiantinsights.com/research/2013-2028-report-on-global-cardiovascular-agents-market/request-sample This report provides detailed historical analysis of global market for Cardiovascular Agents from 2013-2018, and provides extensive market forecasts from 2018-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Cardiovascular Agents market. Leading players of Cardiovascular Agents including: AstraZeneca plc. Pfizer Inc. Novartis AG Merck & Co., Inc. Bristol-Myers Squibb Company Bayer AG Sanofi Boehringer Ingelheim GmbH F. Hoffmann-La Roche Ltd Abbott Laboratories Gilead Sciences, Inc. Johnson & Johns...

Our latest pharmaceutical market report – ‘The Chinese Medical Devices Market to 2025’ covers pharmaceutical, commercial and strategic developments in the Chinese Medical Devices Market across the next decade. We discuss key markets, key products and how the Chinese Medical Device market operates in general. Download free request sample @  https://www.radiantinsights.com/research/the-chinese-medical-devices-market/request-sample Chinese Healthcare spending has risen from $90.8bn in 2004 to reach $590.2bn across 2014, a ten-year CAGR of 20.6%. With increased governmental spend on healthcare, and increasing levels of income for many Chinese citizens, healthcare spend per capita’ is also expected to increase significantly across 2015-2025. Key growth drivers highlighted within ‘The Chinese Medical Devices Market to 2025’ include; growing customer base, in terms of both increased population and increased numbers of health centres; expanding health insurance; a considerable geri...